Phathom Pharmaceuticals (PHAT) Stock Forecast

Analyst ratings, price targets, and earnings estimates.

PHAT Analyst Ratings

Buy

Consensus

Strong Buy
0
Buy
7
Hold
4
Sell
1
Strong Sell
0
58%33%8%

Based on 12 analysts in the past 3 months

PHAT Stock 12 Month Forecast

$18.00

▲ (172.73% Upside)
Highest Price Target
$38.00 (475.8%)
Average Price Target
$18.00 (172.7%)
Lowest Price Target
$12.00 (81.8%)

Based on 1 analysts in the last 3 months

Recent Price Targets
404030302020101000Price Target ($)20232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Recommendation Trends
Strong Buy
Buy
Hold
Sell
Strong Sell
10108866442200332222455566111111Oct 1, 2024Oct 1, 2024Nov 1, 2024Nov 1, 2024Dec 1, 2024Dec 1, 2024Jan 1, 2025Jan 1, 2025Feb 1, 2025Feb 1, 2025Mar 1, 2025Mar 1, 2025
Analyst Estimates
Revenue Estimates
High $204.11M
Average $163.67M
Low $122.57M
6 analysts
Net Income Estimates
High $-213.50M
Average $-253.51M
Low $-293.53M
6 analysts
EPS Estimates
High $-3.38
Average $-4.01
Low $-4.65
4 analysts
Revenue Estimates
High $381.10M
Average $350.04M
Low $326.45M
8 analysts
Net Income Estimates
High $-94.49M
Average $-124.97M
Low $-155.46M
8 analysts
EPS Estimates
High $-1.50
Average $-1.84
Low $-2.46
6 analysts
Revenue Estimates
High $591.87M
Average $591.87M
Low $591.87M
7 analysts
Net Income Estimates
High $131.00M
Average $35.97M
Low $-27.46M
7 analysts
EPS Estimates
High $2.07
Average $0.48
Low $-0.43
6 analysts
Revenue Estimates
High $894.02M
Average $797.18M
Low $700.43M
3 analysts
Net Income Estimates
High $142.36M
Average $122.94M
Low $103.54M
3 analysts
EPS Estimates
High $2.25
Average $1.95
Low $1.64
3 analysts
Revenue Estimates
High $1.09B
Average $974.33M
Low $856.07M
3 analysts
Net Income Estimates
High $236.10M
Average $203.90M
Low $171.73M
3 analysts
EPS Estimates
High $3.74
Average $3.23
Low $2.72
3 analysts
Latest Price Target Updates
Date Analyst Firm Price Target Price When Posted Upside
Mar 07, 2025 Guggenheim $18.00 $5.06 255.7%
Aug 08, 2024 Paul Choi Goldman Sachs $12.00 $11.75 2.1%
Jul 19, 2024 Matthew Caufield H.C. Wainwright $28.00 $10.95 155.8%
May 02, 2024 Annabel Samimy Stifel Nicolaus $24.00 $9.76 145.9%
Jan 05, 2024 Joseph Stringer Needham $26.00 $8.99 189.2%
Jan 04, 2023 None BMO Capital $35.00 $11.99 191.9%
Jan 04, 2023 None Needham $25.00 $11.99 108.5%
Nov 14, 2022 None BMO Capital $38.00 $10.65 256.8%
Nov 11, 2022 None Guggenheim $30.00 $10.78 178.3%

Related Metrics

Explore detailed financial metrics and analysis for PHAT.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio